NCT07264725Completed
Libyan Multiple Sclerosis Registry Study
Multiple Sclerosis Care in a Conflict-Affected Health System: Diagnostic Delay, Treatment Access, and Disability Outcomes in Libya
Source: ClinicalTrials.gov · Last updated 4 Dec 2025
Brief summary (registry, in English)
This study aims to understand differences in access to diagnosis and treatment for people with multiple sclerosis (MS) receiving care in Libya. The study uses data from the Libyan Multiple Sclerosis Registry, which collects clinical and treatment information from patients at two tertiary neurology centres. The main focus is to examine how long it takes for patients to receive an MS diagnosis, who has access to high-efficacy disease-modifying therapies, and how these factors relate to disability levels. The results will help identify gaps in MS care within a conflict-affected health system and guide improvements in services for patients in Libya.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 369 (actual)
- First submitted
- 23 Nov 2025
- Start date
- 2 Aug 2023
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- University of Zintan
- Diseases
- Multiple sclerosis
- NCT number
- NCT07264725
What you commit to
- Study type: Observational
- Participants enrolled: 369
- From 2 Aug 2023 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinically isolated syndrome (CIS)
Age
- Age younger than 18 years
Other
- Absence of confirmed multiple sclerosis diagnosis
- Missing key clinical variables required for primary analysis (EDSS, phenotype, or DMT information)
- Declined or unable to provide informed consent
Who the study is looking for
- Adults aged 18 years or older
- Diagnosis of multiple sclerosis according to the 2017 McDonald criteria
- Receiving care at Tripoli University Hospital or Omar Askar Hospital
- Able to provide written informed consent
- Recorded EDSS score at registry entry
- Availability of core demographic and diagnostic information
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tripoli University Hospital Coordinator of this site? Confirm its status | Zintan | Libya | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.